Advertisement

Delayed Local Reactions to mRNA-1273 Vaccination Reported

0

Reactions appeared near injection site at a median onset of day 8 after first dose; six of 12 patients had no recurrence after second dose

Semaglutide May Aid Weight Loss in Obese Patients With T2DM

0

Estimated change in mean body weight to week 68 was −9.6 percent with semaglutide 2.4 mg versus −3.4 percent with placebo

Shortage of Syringes Reported for COVID-19 Shots

0

Billions poured into development of vaccines, but little public investment made in expanding manufacturing for syringes

Terlipressin Bests Placebo in Type 1 Hepatorenal Syndrome

0

Terlipressin is more effective for reversal of HRS but is associated with more adverse events and death due to respiratory disorders

California Targets Vulnerable Neighborhoods for COVID-19 Vaccination

0

Neighborhoods considered highly vulnerable based on factors such as income, education, housing, and transportation

COVID-19 Death Rates 10 Times Higher in Countries Where Most Are Overweight

0

Higher BMI also associated with increased risk for hospitalization, ICU admission, need for mechanical ventilation

Uptake of Seasonal Influenza Vaccine Lower Among Minorities

0

Uptake lower among Black, Asian, Hispanic adults versus Whites; those vaccinated less likely to receive high-dose vaccine

Good Response Seen With HealthCare.gov Reopening

0

CMS figures show more than 206,000 people signed up for coverage from Feb. 15 to 28

AAN: Antidepressants Not Tied to Increased Intracerebral Hemorrhage Risk

0

Selective serotonin reuptake inhibitors are not associated with higher risk for intracerebral hemorrhage